AGUIAR ERIC

10% owner at REPLIDYNE INC · on record since Jun 27, 2006
10% owner at ADVANCIS PHARMACEUTICAL CORP · on record since Apr 13, 2007
member of Section 13(d) group at HEALTHCARE ACQUISITION CORP · on record since Aug 7, 2007
10% owner at HEALTHCARE ACQUISITION CORP · on record since Aug 7, 2007
10% owner at CRITICAL THERAPEUTICS INC · on record since May 26, 2004
10% owner at TRANZYME INC · on record since Jul 24, 2013
Director at Biomea Fusion, Inc. · on record since Jun 12, 2026
Director at Invitae Corp · on record since Feb 18, 2015
10% owner at Invitae Corp · on record since Feb 18, 2015
Director at Biohaven Ltd. · on record since May 3, 2017
Director at Eidos Therapeutics, Inc. · on record since Jun 19, 2018
10% owner at Eidos Therapeutics, Inc. · on record since May 29, 2019
Director at BridgeBio Pharma, Inc. · on record since Jun 27, 2019

Insider trading activity of AGUIAR ERIC

Figures computed from official regulatory filings — methodology.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Company	Filed	Type	Qty	Value · USD	Src
BridgeBio Pharma, Inc.	Jun 24, 2026	AwardD	5,277	—	SEC
BridgeBio Pharma, Inc.	Jun 24, 2026	Award	3,990	—	SEC
Biomea Fusion, Inc.	Jun 12, 2026	AwardD	196,299	$0	SEC
BridgeBio Pharma, Inc.	Jun 24, 2025	Award	6,589	$0	SEC
BridgeBio Pharma, Inc.	Jun 24, 2025	AwardD	8,425	$0	SEC
Biomea Fusion, Inc.	Jun 13, 2025	AwardD	91,970	$0	SEC
BridgeBio Pharma, Inc.	Jun 25, 2024	AwardD	26,014	$0	SEC
Biomea Fusion, Inc.	Jun 13, 2024	AwardD	51,025	$0	SEC
BridgeBio Pharma, Inc.	Jun 23, 2023	AwardD	51,501	$0	SEC
Biomea Fusion, Inc.	Jun 16, 2023	AwardD	6,989	$0	SEC
Invitae Corp	May 1, 2023	Award	70,422	$0	SEC
Invitae Corp	May 1, 2023	AwardD	28,901	$0	SEC
Biomea Fusion, Inc.	Jun 24, 2022	AwardD	23,867	$0	SEC
BridgeBio Pharma, Inc.	Jun 24, 2022	AwardD	104,921	$0	SEC
Invitae Corp	May 2, 2022	AwardD	5,700	$0	SEC
Invitae Corp	May 2, 2022	Award	32,100	$0	SEC
Invitae Corp	May 2, 2022	AwardD	16,100	$0	SEC
Invitae Corp	May 2, 2022	Award	11,300	$0	SEC
BridgeBio Pharma, Inc.	Jun 22, 2021	AwardD	38,895	$0	SEC
Invitae Corp	May 4, 2021	AwardD	1,500	$0	SEC
Invitae Corp	May 4, 2021	Award	3,000	$0	SEC
Invitae Corp	May 4, 2021	Award	8,500	$0	SEC
Invitae Corp	May 4, 2021	AwardD	4,400	$0	SEC
Biomea Fusion, Inc.	Apr 19, 2021	AwardD	28,911	$0	SEC
Invitae Corp	Dec 18, 2020	ExerciseD	-10,000	$0	SEC

Company	Filed	Type	Qty	Value · USD	Src
BridgeBio Pharma, Inc.	Jun 24, 2026	AwardD	5,277	—	SEC
BridgeBio Pharma, Inc.	Jun 24, 2026	Award	3,990	—	SEC
Biomea Fusion, Inc.	Jun 12, 2026	AwardD	196,299	$0	SEC
BridgeBio Pharma, Inc.	Jun 24, 2025	Award	6,589	$0	SEC
BridgeBio Pharma, Inc.	Jun 24, 2025	AwardD	8,425	$0	SEC
Biomea Fusion, Inc.	Jun 13, 2025	AwardD	91,970	$0	SEC
BridgeBio Pharma, Inc.	Jun 25, 2024	AwardD	26,014	$0	SEC
Biomea Fusion, Inc.	Jun 13, 2024	AwardD	51,025	$0	SEC
BridgeBio Pharma, Inc.	Jun 23, 2023	AwardD	51,501	$0	SEC
Biomea Fusion, Inc.	Jun 16, 2023	AwardD	6,989	$0	SEC
Invitae Corp	May 1, 2023	Award	70,422	$0	SEC
Invitae Corp	May 1, 2023	AwardD	28,901	$0	SEC
Biomea Fusion, Inc.	Jun 24, 2022	AwardD	23,867	$0	SEC
BridgeBio Pharma, Inc.	Jun 24, 2022	AwardD	104,921	$0	SEC
Invitae Corp	May 2, 2022	AwardD	5,700	$0	SEC
Invitae Corp	May 2, 2022	Award	32,100	$0	SEC
Invitae Corp	May 2, 2022	AwardD	16,100	$0	SEC
Invitae Corp	May 2, 2022	Award	11,300	$0	SEC
BridgeBio Pharma, Inc.	Jun 22, 2021	AwardD	38,895	$0	SEC
Invitae Corp	May 4, 2021	AwardD	1,500	$0	SEC
Invitae Corp	May 4, 2021	Award	3,000	$0	SEC
Invitae Corp	May 4, 2021	Award	8,500	$0	SEC
Invitae Corp	May 4, 2021	AwardD	4,400	$0	SEC
Biomea Fusion, Inc.	Apr 19, 2021	AwardD	28,911	$0	SEC
Invitae Corp	Dec 18, 2020	ExerciseD	-10,000	$0	SEC